Sarwar Beg

9.6k total citations
210 papers, 6.6k citations indexed

About

Sarwar Beg is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Sarwar Beg has authored 210 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pharmaceutical Science, 48 papers in Molecular Biology and 42 papers in Biomaterials. Recurrent topics in Sarwar Beg's work include Advanced Drug Delivery Systems (54 papers), Drug Solubulity and Delivery Systems (53 papers) and Nanoparticle-Based Drug Delivery (39 papers). Sarwar Beg is often cited by papers focused on Advanced Drug Delivery Systems (54 papers), Drug Solubulity and Delivery Systems (53 papers) and Nanoparticle-Based Drug Delivery (39 papers). Sarwar Beg collaborates with scholars based in India, Saudi Arabia and United Kingdom. Sarwar Beg's co-authors include Bhupinder Singh, Om Prakash Katare, Mahfoozur Rahman, Suryakanta Swain, Kanchan Kohli, Farhan Jalees Ahmad, Md. Abul Barkat, Gajanand Sharma, Premjeet Singh Sandhu and Waleed Hassan Almalki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Journal of Controlled Release.

In The Last Decade

Sarwar Beg

207 papers receiving 6.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sarwar Beg 2.4k 1.6k 1.3k 1.1k 734 210 6.6k
Brigitte Évrard 2.2k 0.9× 1.5k 0.9× 894 0.7× 972 0.9× 601 0.8× 189 5.7k
Jeong‐Sook Park 2.4k 1.0× 1.7k 1.0× 1.1k 0.9× 858 0.8× 741 1.0× 248 6.1k
Bhupinder Singh 3.5k 1.4× 1.5k 0.9× 1.1k 0.9× 568 0.5× 664 0.9× 174 6.9k
Hadi Valizadeh 2.4k 1.0× 2.2k 1.4× 1.7k 1.3× 1.0k 0.9× 824 1.1× 244 7.0k
Sultan Alshehri 1.9k 0.8× 1.6k 1.0× 1.0k 0.8× 925 0.8× 1.4k 2.0× 389 7.5k
Beom‐Jin Lee 3.6k 1.5× 1.4k 0.8× 1.4k 1.1× 942 0.9× 1.3k 1.8× 215 6.6k
Chul Soon Yong 1.9k 0.8× 1.4k 0.9× 1.5k 1.2× 1.3k 1.2× 908 1.2× 108 4.8k
Pradeep R. Vavia 3.4k 1.4× 1.1k 0.7× 1.3k 1.0× 587 0.5× 514 0.7× 147 5.4k
Srinivas Mutalik 2.1k 0.9× 1.4k 0.8× 1.2k 0.9× 1.2k 1.1× 1.0k 1.4× 276 6.4k
Sushama Talegaonkar 3.9k 1.6× 1.8k 1.1× 1.8k 1.4× 1.1k 1.0× 1.1k 1.5× 202 9.2k

Countries citing papers authored by Sarwar Beg

Since Specialization
Citations

This map shows the geographic impact of Sarwar Beg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarwar Beg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarwar Beg more than expected).

Fields of papers citing papers by Sarwar Beg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarwar Beg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarwar Beg. The network helps show where Sarwar Beg may publish in the future.

Co-authorship network of co-authors of Sarwar Beg

This figure shows the co-authorship network connecting the top 25 collaborators of Sarwar Beg. A scholar is included among the top collaborators of Sarwar Beg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarwar Beg. Sarwar Beg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilles, Ayah Rebhi, et al.. (2024). Recent advancements in the cancer vaccines: A review. Journal of Drug Delivery Science and Technology. 102. 106422–106422.
2.
Beg, Sarwar, et al.. (2024). Nondestructive techniques for pharmaceutical drug product characterization. Drug Discovery Today. 30(1). 104249–104249. 1 indexed citations
3.
Kazmi, Imran, Fahad A. Al‐Abbasi, Ryan A. Sheikh, et al.. (2024). Malvidin attenuates behavioral and inhibits the TNF-α/Caspase-3/Nrf-2 expression in rotenone-induced Parkinson's disease in rats: insights from molecular docking.. PubMed. 28(9). 3330–3346. 2 indexed citations
4.
5.
Beg, Sarwar, Obaid Afzal, Imran Kazmi, et al.. (2023). Natural microbial surfactant containing self-nanoemulsifying formulation with improved performance of paclitaxel therapy: A newer avenue in breast cancer treatment. Journal of Drug Delivery Science and Technology. 90. 105105–105105. 2 indexed citations
6.
Alqahtani, Safar M., Ali Altharawi, Majed Alrobaian, et al.. (2023). UPLC–MS/MS Method Development for Simultaneous Estimation of Diclofenac and Resveratrol-Loaded Liposomal Gel Formulation in Mice Skin Model: Application to Dermatokinetic Study. Journal of Chromatographic Science. 61(4). 329–338. 2 indexed citations
7.
Altharawi, Ali, Safar M. Alqahtani, Sagar Suman Panda, et al.. (2023). UPLC-MS/MS Method for Simultaneous Estimation of Neratinib and Naringenin in Rat Plasma: Greenness Assessment and Application to Therapeutic Drug Monitoring. Separations. 10(3). 167–167. 1 indexed citations
8.
Rahman, Mahfoozur, Waleed Hassan Almalki, Majed Alrobaian, Sarwar Beg, & Khalid Saad Alharbi. (2022). Hormone Related Cancer Mechanistic and Nanomedicines. 1 indexed citations
9.
Beg, Sarwar, Ankit Kumar Malik, Mohammad Javed Ansari, et al.. (2022). Systematic Development of Solid Lipid Nanoparticles of Abiraterone Acetate with Improved Oral Bioavailability and Anticancer Activity for Prostate Carcinoma Treatment. ACS Omega. 7(20). 16968–16979. 30 indexed citations
10.
Alhalmi, Abdulsalam, et al.. (2020). Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting. Current Drug Targets. 22(7). 779–792. 20 indexed citations
11.
12.
Rahman, Mahfoozur & Sarwar Beg. (2019). Hitting the target – refining anticancer nanomedicine development. 24(4). 14–16. 3 indexed citations
13.
Rahman, Mahfoozur, Shareefa A. AlGhamdi, Khalid Saad Alharbi, et al.. (2019). Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma. Drug Delivery. 26(1). 782–793. 64 indexed citations
14.
Beg, Sarwar, Sunil Kumar Panda, Mahfoozur Rahman, et al.. (2019). Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems. Seminars in Cancer Biology. 69. 249–267. 36 indexed citations
15.
Beg, Sarwar, Mahfoozur Rahman, & Sagar Suman Panda. (2017). Pharmaceutical QbD: Omnipresence in the product development lifecycle. 22(1). 58–64. 23 indexed citations
16.
Sandhu, Premjeet Singh, Sarwar Beg, Om Prakash Katare, & Bhupinder Singh. (2016). QbD-Driven Development and Validation of a HPLC Method for Estimation of Tamoxifen Citrate with Improved Performance. Journal of Chromatographic Science. 54(8). 1373–1384. 81 indexed citations
17.
Swain, Suryakanta, et al.. (2016). Nanoparticles for Cancer Targeting: Current and Future Directions. Current Drug Delivery. 13(8). 1290–1302. 130 indexed citations
18.
Bansal, Sanjay, Sarwar Beg, Abhay Asthana, et al.. (2014). QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride. Drug Delivery. 23(2). 437–451. 37 indexed citations
19.
Swain, Suryakanta, Sarwar Beg, Chinam Niranjan Patra, et al.. (2012). Modified Alginate Beads for Mucoadhesive Drug Delivery System: An Updated Review of Patents. Recent Patents on Drug Delivery & Formulation. 6(3). 259–277. 16 indexed citations
20.
Beg, Sarwar, et al.. (2011). Dendrimers as Novel Systems for Delivery of Neuropharmaceuticals to the Brain. CNS & Neurological Disorders - Drug Targets. 10(5). 576–588. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigitte Évrard Breakdown of academic impact, for papers by Jeong‐Sook Park Breakdown of academic impact, for papers by Bhupinder Singh Breakdown of academic impact, for papers by Hadi Valizadeh Breakdown of academic impact, for papers by Sultan Alshehri Breakdown of academic impact, for papers by Beom‐Jin Lee Breakdown of academic impact, for papers by Chul Soon Yong Breakdown of academic impact, for papers by Pradeep R. Vavia Breakdown of academic impact, for papers by Srinivas Mutalik Breakdown of academic impact, for papers by Sushama Talegaonkar
Rankless by CCL
2026